Definition
The principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle.
Description
Morphine is only found in individuals that have used or taken this drug. It is the principal alkaloid in opium and the prototype opiate analgesic and narcotic. Morphine has widespread effects in the central nervous system and on smooth muscle. The precise mechanism of the analgesic action of morphine is unknown. However, specific CNS opiate receptors have been identified and likely play a role in the expression of analgesic effects. Morphine first acts on the mu-opioid receptors. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and to electrical stimulation.It has been shown that morphine binds to and inhibits GABA inhibitory interneurons. These interneurons normally inhibit the descending pain inhibition pathway. So, without the inhibitory signals, pain modulation can proceed downstream.
Top Gene Interactions
Related Pathways
General Information
- Metabolism: Primarily hepatic (90%), converted to dihydromorphinone and normorphine. Also converted to morphine-3-glucuronide (M3G) and morphine-6-glucuronide. Virtually all morphine is converted to glucuronide metabolites; only a small fraction (less than 5%) of absorbed morphine is demethylated. Route of Elimination: A small amount of glucuronide conjugates are excreted in bile, with minor enterohepatic recycling. Seven to 10% of administered morphine sulfate is excreted in the feces. Half Life: 2-4 hours
- Uses/Sources: For the relief and treatment of severe pain.
- Health Effects: Medical problems can include congested lungs, liver disease, tetanus, infection of the heart valves, skin abscesses, anemia and pneumonia. Death can occur from overdose.
- Symptoms: Symptoms of overdose include cold, clammy skin, flaccid muscles, fluid in the lungs, lowered blood pressure, "pinpoint" or dilated pupils, sleepiness leading to stupor and coma, slowed breathing, and slow pulse rate.
- Treatment: In the treatment of morphine overdosage, primary attention should be given to the re- establishment of a patent airway and institution of assisted or controlled ventilation. Supportive measures (including oxygen, vasopressors) should be employed in the management of circulatory shock and pulmonary edema accompanying overdose as indicated. Cardiac arrest or arrhythmias may require cardiac massage or defibrillation. The pure opioid antagonists, such as naloxone, are specific antidotes against respiratory depression which results from opioid overdose. Naloxone should be administered intravenously; however, because its duration of action is relatively short, the patient must be carefully monitored until spontaneous respiration is reliably re-established. If the response to naloxone is suboptimal or not sustained, additional naloxone may be administered, as needed, or given by continuous infusion to maintain alertness and respiratory function; however, there is no information available about the cumulative dose of naloxone that may be safely administered. (L1712)
- Route of Exposure: Intravenous, Topical, Oral, Intramuscular, Epidural, Rectal. Bioavailability is approximately 30%.
Toxicity
- Carcinogenicity: No indication of carcinogenicity to humans (not listed by IARC).
- Toxicity: LD50: 461 mg/kg (oral, rat) LD50: 600 mg/kg (oral, mouse)
- Lethal Dose: Human lethal dose by ingestion is 120-250 mg of morphine sulfate.
Mechanism of Action
Target Name | Mechanism of Action | References |
---|---|---|
Potassium voltage-gated channel subfamily H member 2 Cytochrome P450 3A4 Multidrug resistance protein 1 Sigma non-opioid intracellular receptor 1 Solute carrier family 22 member 1 Nociceptin receptor Toll-like receptor 4 |
20178837 12699389 7932535 16777416 18788725 15911273 |
|
Mu-type opioid receptor Kappa-type opioid receptor Delta-type opioid receptor |
The precise mechanism of the analgesic action of morphine is unknown. However, specific CNS opiate receptors have been identified and likely play a role in the expression of analgesic effects. The mechanism of respiratory depression involves a reduction in the responsiveness of the brain stem respiratory centers to increases in carbon dioxide tension and to electrical stimulation. |
11000010 12930147 22439881 16580639 1323679 16534251 17887741 1659636 15055988 19932964 12502358 2832603 16650582 16580848 9651168 22995061 17656655 16753266 7739011 9686407 16678156 8642567 2887656 22680612 21570305 1652025 23419026 19627147 17016423 7932177 1846918 9808678 2831363 1846921 21621410 12166947 16682505 9873603 7959748 11752352 1315868 21684752 7739013 12699394 2567782 14998329 17145705 16539674 9873439 8642554 8390575 17139284 16530171 22341895 16913723 8114680 20478711 16392810 1967312 16708053 |